ANTX News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$135.9M

Volume

269.57K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsightThe nontuberculous mycobacterial (NTM) infections market is projected to grow at a CAGR of 12.6% from 2026-2036, valued at USD 750 million in 2025. Growth is driven by rising disease prevalence, improved diagnostics, and emerging therapies including Omadacycline (NUZYRA), MRX-5, Epetraborole, and RHB-204. The US represents the largest market with approximately 400,000 diagnosed NTM cases across the 7MM countries.GlobeNewswire Inc. · Aug 31, 2026

Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutics (ANTX) Looks Ripe for a TurnaroundAN2 Therapeutics (ANTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.Zacks Investment Research · May 21, 2024

ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For TuesdayTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for monday.com Ltd. (NASDAQ: MNDY) from $238 to $242. Keybanc analyst Jason Celino maintained an Overweight rating. monday.com shares dipped 10.1% to close at $212.01 on Monday. See how other analysts view this stock. Needham cut G1 Therapeutics, Inc. (NASDAQ: GTHX) price target from $14 to $12. Needham analyst Gil Blum maintained a Buy rating. G1 Therapeutics shares fell 1.1% to close at $4.48 on Monday. See how other analysts view this stock. Needham boosted the price target for Cadence Design Systems, Inc. (NASDAQ: CDNS) from $315 to $320. Needham analyst Charles Shi maintained a Buy rating. Cadence Design shares fell 1.7% to close at $306.58 on Monday. See how other analysts view this stock. B. Riley Securities cut The Children's Place, Inc. (NASDAQ:Benzinga · Feb 13, 2024

Nasdaq Edges Lower; ContextLogic Shares SurgeU.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightly lower on Monday. The Dow traded up 0.52% to 38,873.28 while the NASDAQ fell 0.10% to 15,975.16. The S&P 500 also rose, gaining, 0.12% to 5,032.46. Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades' Leading and Lagging Sectors Energy shares rose by 1.1% on Monday. In trading on Monday, health care shares fell by 0.1%. Top Headline Martin Marietta Materials Inc (NYSE: MLM) disclosed a deal to acquire 20 active operations in Alabama, South Carolina, South Florida, Tennessee, and Virginia from affiliates of Blue Water Industries LLC (BWI Southeast) for $2.05 billion in cash. Equities Trading UP Beamr Imaging Ltd. (NASDAQ: BMR) shares shot up 1,082% to $24.96 after the company announced it will present joint research relating to automated video modernization with Nvidia at the ACM Mile-High-Video 2024 conference. Shares of ...Benzinga · Feb 12, 2024

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day SessionShares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1. Big Lots shares dipped 31.3% to $3.6850 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Millennium Group International Holdings Limited (NASDAQ: MGIH) surged 250% to $3.61 after YC 1926 (BVI) Limited reported an 88.89% stake in the company in a 13G filing on Friday. Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 241.5% to $7.20 after the company announced it will present its joint research relating to automated video modernization with NVIDIA at the ACM Mile-High-Video 2024 conference. DIH Holdings US, Inc. (NASDAQ: DHAI) shares climbed 65.2% to $2.1306. DIH Holding US secured $1.5 million in private placement financing from OrbiMed. ContextLogic Inc. (NASDAQ: WISH) gained 40.2% to $6.31 after the company announced an agreement to sell substantially all of its operating assets and liabilities to Qoo10 for approximately $173 million in cash. SuperCom Ltd. (NASDAQ: SPCB) shares jumped 40% to $0.2570. SuperCom recently disclosed that it has secured a new contract with an established California services provider in the judicial sector. Intuitive Machines, Inc. (NASDAQ: LUNR) shares gained 33.3% to $6.65 after jumping around 32% on Friday. D-Wave Quantum Inc. (NYSE: QBTS) gained 31% to $1.4295. Renalytix Plc (NASDAQ: RNLX) surged 27% to $0.4842. Genasys Inc. (NASDAQ: GNSS) gained 27% to $1.98. Genasys bagged critical infrastructure project to engineer, procure and build emergency warning system for 37 dams across the island of Puerto Rico. Root, Inc. (NASDAQ: ROOT) rose 22.6% to $9.30. Syra Health Corp. (NASDAQ: SYRA) ...Benzinga · Feb 12, 2024

Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3BU.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Monday. The Dow traded up 0.48% to 38,856.99 while the NASDAQ rose 0.26% to 16,031.87. The S&P 500 also rose, gaining, 0.30% to 5,041.87. Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades' Leading and Lagging Sectors Energy shares rose by 1.1% on Monday. In trading on Monday, health care shares fell by 0.1%. Top Headline Gilead Sciences Inc (NASDAQ: GILD) agreed to acquire CymaBay Therapeutics Inc (NASDAQ: CBAY) for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver portfolio. Equities Trading UP Beamr Imaging Ltd. (NASDAQ: BMR) shares shot up 975% to $22.70 after the company announced it will present its joint ...Benzinga · Feb 12, 2024

US Stocks Mixed; Trimble Issues Weak OutlookU.S. stocks traded mixed this morning, with the Dow Jones index falling around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.05% to 38,651.80 while the NASDAQ rose 0.09% to 16,004.39. The S&P 500 also rose, gaining, 0.01% to 5,026.74. Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades' Leading and Lagging Sectors Energy shares rose by 0.8% on Monday. In trading on Monday, health care shares fell by 0.3%. Top Headline Trimble Inc (NASDAQ: TRMB) reported upbeat earnings for its fourth quarter, but issued weak forecast for the first quarter. Trimble reported a fourth-quarter FY23 revenue growth of 9% to $932.40 million, beating the consensus of $909.53 million. Revenue grew by 3% Y/Y on an organic basis. The adjusted EPS of $0.63 beat the consensus of $0.59. Trimble said it anticipates fiscal 2024 revenue of $3.57 billion – $3.67 billion, below the consensus of $3.84 billion. It also expects adjusted EPS of $2.60 – $2.80 against ...Benzinga · Feb 12, 2024

Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market SessionU.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday. Shares of monday.com Ltd. (NASDAQ: MNDY) fell sharply in today’s pre-market trading after the company reported fourth-quarter financial results. Monday.com posted adjusted earnings of 65 cents per share on sales of $202.57 million. monday.com shares dipped 9% to $214.69 in pre-market trading. Here are some big stocks recording losses in today’s pre-market trading session. AN2 Therapeutics, Inc. (NASDAQ: ANTX) shares dipped 72% to $5.59 in pre-market trading as the company said it will voluntarily pause ...Benzinga · Feb 12, 2024

Recent Price Trend in AN2 Therapeutics, Inc. (ANTX) is Your Friend, Here's WhyAN2 Therapeutics, Inc. (ANTX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.Zacks Investment Research · Jan 10, 2024

AN2 Therapeutics, Inc. (ANTX) Is a Great Choice for 'Trend' Investors, Here's WhyAN2 Therapeutics, Inc. (ANTX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.Zacks Investment Research · Nov 6, 2023

ANTXAN2 Therapeutics, Inc. Common Stock

ANTX

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any ANTX yet.

Related Tickers

Earnings

Mkt Cap

$127.9M

Volume

269.57K

Next Earnings

November 11th